funding totaling $3 million in aggregate in Common Stock of Vycor or in securities convertible into Common Stock of Vycor at a price of no less than $0.0125 per share of Common Stock be closed during the term of the Consulting Agreement.  All warrants are exercisable over a five-year term.

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

Effective as of February 10, 2010, the board of directors of Vycor Medical, Inc. (the “Company or “Vycor”) appointed two additional directors of the Company, which will bring the total number of directors serving the Company to six.  The following new directors were appointed:

Adrian Christopher Liddell (51) He is a principal of Fountainhead Capital Partners Limited, an investment company based in Jersey, Channel Islands, which invests in, raises capital for and provides strategic advice to growth companies in healthcare and other sectors. Mr. Liddell has 30 years of strategic, corporate and financial advisory and company investment. From 2003-2006, Mr. Liddell was an investment advisor at Phoenix Equity Partners, a European private equity fund. From 1998 to 2003, Mr. Liddell served as Managing Director, Mergers & Acquisitions at Donaldson Lufkin & Jenrette and then Citigroup in London. From 1984 to 1998, Mr. Liddell held various positions at Samuel Montagu & Co, Lehman Brothers and Erik Penser Corporate Finance in London. Mr. Liddell qualified as a Chartered Accountant in 1984 and holds an MA from Christ’s College, Cambridge University.

David Marc Cantor (43) He is a founding principal of Fountainhead Capital Partners Limited, an investment company based in Jersey, Channel Islands, which invests in, raises capital for and provides strategic advice to growth companies across a broad range of sectors.  Mr. Cantor has over 22 years experience in Investment Banking with a focus on Mergers and Acquisitions and Equity Capital Raisings. Prior to Fountainhead from 2001 – 2005 he was at Citigroup Capital Markets where he was Co-head of its European Business Development and subsequently European Head of its Diversified Industrials and Aerospace activities. Prior to Citigroup he was a Managing Director in M&A at Donaldson Lufkin & Jenrette and worked at Lehman Brothers both in New York and London in both the Equity capital and M&A groups. Mr. Cantor has a BSc with Honours from City Business School, London.

Both directors will serve until their successors are appointed or the next stockholders’ meeting where directors are elected.  Each of Messrs. Liddell and Cantor act as Investment Manager pursuant to individual Investment Management Agreements with Fountainhead Capital Management Limited (“FHM”), the largest stockholder of the Company, which currently holds approximately 85% of the issued and outstanding shares of the Company’s Common Stock.  In addition, FHM is a holder of the Company’s Debentures and is party to a Shareholder’s Agreement with the Company (as disclosed on the Company’s Current report on Form 8-K filed with the U.S. Securities and Exchange Commission on January 6, 2010, which is incorporated herein in its entirety by this reference) and a Consulting Agreement which is described in Item 1.01, above.